Methocinnamox is a Potent and Long-Acting Antagonist that can Prevent and Reverse Opioid-Induced Respiratory Depression

Affiliations

¹ Department of Biology, Texas Tech University, Lubbock, Texas (J.A.C.) and Department of Biomedical Sciences, Marshall University, Huntington, West Virginia (D.J.M.).
² Department of Biology, Texas Tech University, Lubbock, Texas (J.A.C.) and Department of Biomedical Sciences, Marshall University, Huntington, West Virginia (D.J.M.) morganda@marshall.edu.

James A Carr et al. J Pharmacol Exp Ther. 2024.

. 2024 Sep 18;391(1):1-3.

doi: 10.1124/jpet.124.002205.

¹ Department of Biology, Texas Tech University, Lubbock, Texas (J.A.C.) and Department of Biomedical Sciences, Marshall University, Huntington, West Virginia (D.J.M.).
² Department of Biology, Texas Tech University, Lubbock, Texas (J.A.C.) and Department of Biomedical Sciences, Marshall University, Huntington, West Virginia (D.J.M.) morganda@marshall.edu.

No abstract available

References

1. Bentley JB, Borel JD, Nenad RE Jr, Gillespie TJ (1982) Age and fentanyl pharmacokinetics. Anesth Analg 61:968–971. - PubMed
1. Blumberg H, Dayton HB, George M, Rapaport DN (1961) N-allylnoroxymorphone: A potent narcotic antagonist. Fed Proc 20:311.
1. Britch SC, Walsh SL (2022) Treatment of opioid overdose: current approaches and recent advances. Psychopharmacology (Berl) 239:2063–2081. - PMC - PubMed
1. Crystal R, Ellison M, Purdon C, Skolnick P (2024) Pharmacokinetic Properties of an FDA-approved Intranasal Nalmefene Formulation for the Treatment of Opioid Overdose. Clin Pharmacol Drug Dev 13:58–69. - PMC - PubMed
1. Ellison M, Hutton E, Webster L, Skolnick P (2024) Reversal of Opioid-Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone. J Clin Pharmacol. - PubMed